BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26399862)

  • 1. Utility of molecular testing in the management of thyroid nodules - a clinical perspective.
    Elaraj D; Nayar R; Sturgeon C
    Cytopathology; 2015 Oct; 26(5):284-7. PubMed ID: 26399862
    [No Abstract]   [Full Text] [Related]  

  • 2. What is the role of molecular markers in the management of "indeterminate" thyroid nodules?
    Daniels GH
    Cancer Cytopathol; 2013 May; 121(5):223-4. PubMed ID: 23670834
    [No Abstract]   [Full Text] [Related]  

  • 3. Lessons from early clinical experience with the Afirma gene expression classifier.
    Krane JF
    Cancer Cytopathol; 2014 Oct; 122(10):715-9. PubMed ID: 25123593
    [No Abstract]   [Full Text] [Related]  

  • 4. Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules.
    Beaudenon-Huibregtse S; Alexander EK; Guttler RB; Hershman JM; Babu V; Blevins TC; Moore P; Andruss B; Labourier E
    Thyroid; 2014 Oct; 24(10):1479-87. PubMed ID: 24811481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indeterminate Thyroid Nodules and Advances in Molecular Pathology.
    Belovarac B; Zhou F; Sharma J; Brandler TC
    Semin Diagn Pathol; 2023 Sep; 40(5):349-352. PubMed ID: 37173165
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Endo M; Nabhan F; Angell TE; Harrell RM; Nasr C; Wei S; Sipos JA
    Thyroid; 2020 Sep; 30(9):1390-1392. PubMed ID: 32228149
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular cytopathology for thyroid nodules: A review of methodology and test performance.
    Nishino M
    Cancer Cytopathol; 2016 Jan; 124(1):14-27. PubMed ID: 26348024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dignity of thyroid nodules: diagnostic gain by molecular fine needle aspiration cytology].
    Eszlinger M; Ruschenburg I; Paschke R
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2003-6. PubMed ID: 24065405
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of fine-needle aspiration and fine-needle capillary sampling of thyroid nodules: a prospective study with emphasis on the influence of nodule size.
    Zhou JQ; Zhang JW; Zhan WW; Zhou W; Ye TJ; Zhu Y; Yao JJ; Liu J; Hu YY; Grant EG
    Cancer Cytopathol; 2014 Apr; 122(4):266-73. PubMed ID: 24302655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.
    Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D
    Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating benign from malignant thyroid nodules using micro ribonucleic acid amplification in residual cells obtained by fine needle aspiration biopsy.
    Mazeh H; Levy Y; Mizrahi I; Appelbaum L; Ilyayev N; Halle D; Freund HR; Nissan A
    J Surg Res; 2013 Apr; 180(2):216-21. PubMed ID: 22626557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine needle aspiration biopsy of thyroid nodules in children and adolescents.
    Chang SH; Joo M; Kim H
    J Korean Med Sci; 2006 Jun; 21(3):469-73. PubMed ID: 16778391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The utility of molecular markers in pre-operative assessment of thyroid nodules.
    Bhatia P; Abd Elmageed ZY; Friedlander P; Aslam R; Kandil E
    Future Oncol; 2015; 11(16):2343-50. PubMed ID: 26260812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fine-needle aspiration biopsy in the management of palpable thyroid nodules.
    Greenspan FS
    Am J Clin Pathol; 1997 Oct; 108(4 Suppl 1):S26-30. PubMed ID: 9322610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ; Kim EK; Kwak JY
    Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular diagnosis and management of thyroid neoplasms.
    Theoharis C; Roman S; Sosa JA
    Curr Opin Oncol; 2012 Jan; 24(1):35-41. PubMed ID: 22123232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodules.
    Jackson S; Kumar G; Banizs AB; Toney N; Silverman JF; Narick CM; Finkelstein SD
    Diagn Cytopathol; 2020 Jan; 48(1):43-52. PubMed ID: 31675178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fine-needle aspiration biopsy of thyroid nodules: Determining when it is necessary.
    Song JSA; Hart RD
    Can Fam Physician; 2018 Feb; 64(2):127-128. PubMed ID: 29449244
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.
    Keutgen XM; Filicori F; Fahey TJ
    Expert Rev Mol Diagn; 2013 Jul; 13(6):613-23. PubMed ID: 23895130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.